LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

Home・Lista de Ações・MannKind Corp

MannKind Corp

Fechado

SetorSaúde

3.56 0.28

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3.43

Máximo

3.61

Indicadores-chave
By Trading Economics
Rendimento	-671K -17M
Vendas	-22M 90M
P/E Médio do Setor	140.5 50.102
EPS	-0.02
Margem de lucro	-18.431
Funcionários	591
EBITDA	5.9M 3.4M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+116.15% upside

Dividendos
By Dow Jones
Próximos Ganhos	5 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	177M 1B
Abertura anterior	3.28
Fecho anterior	3.56

Sentimento de Notícias

By Acuity

37%

63%

79 / 344 Ranking em Healthcare

MannKind Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de mai. de 2026, 21:33 UTC

Ganhos

Correction to Salesforce 1Q Sales, Profit Rise Article

27 de mai. de 2026, 21:00 UTC

Aquisições, Fusões, Aquisições de Empresas

HCA Healthcare Agrees to Buy The College of Health Care Professions

27 de mai. de 2026, 20:18 UTC

Ganhos

Salesforce 1Q Sales, Profit Rise Amid Agentforce Efforts

27 de mai. de 2026, 23:49 UTC

Conversa de Mercado

Nikkei Might Decline Amid Uncertainty Over Potential U.S.-Iran Peace Deal -- Market Talk

27 de mai. de 2026, 23:39 UTC

Conversa de Mercado

Congo Copper, Cobalt Mining Not yet Seen Affected by Ebola Outbreak -- Market Talk

27 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Infratil's Longroad Energy Considers Data-Center Strategy -- Market Talk

27 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

27 de mai. de 2026, 23:08 UTC

Conversa de Mercado

Chinese Coal-Mine Disruptions Could Be Major Supply Shock for Global Markets -- Market Talk

27 de mai. de 2026, 22:21 UTC

Conversa de Mercado

Salesforce Lays Out AI Monetization Strategy -- Market Talk

27 de mai. de 2026, 21:29 UTC

Ações em Alta

Stocks to Watch: Marvell Technology, PDD, Zscaler -- WSJ

27 de mai. de 2026, 21:08 UTC

Ganhos

Marvell's Data-Center Boom Powers Earnings Beat. Its Stock Surges. -- Barrons.com

27 de mai. de 2026, 21:02 UTC

Ganhos

Salesforce Stock Slides on Mixed Results. CFO Touts New Pricing Model. -- Barrons.com

27 de mai. de 2026, 20:59 UTC

Aquisições, Fusões, Aquisições de Empresas

What to Know About Pasqal, the Quantum Start-Up Going Public Soon -- Barrons.com

27 de mai. de 2026, 20:55 UTC

Ganhos

Snowflake Stock Jumps 34%. How Amazon and an Earnings Beat Are Fueling the Gains. -- Barrons.com

27 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

27 de mai. de 2026, 20:48 UTC

Ganhos

Marvell's Data-Center Boom Powers Earnings Beat -- and a Big Stock Surge -- Barrons.com

27 de mai. de 2026, 20:45 UTC

Ganhos

Marvell Stock Jumps on Earnings. Data-Center Revenue Is Still Booming. -- Barrons.com

27 de mai. de 2026, 20:34 UTC

Aquisições, Fusões, Aquisições de Empresas

Webster Financial Stockholders Approve Sale to Banco Santander

27 de mai. de 2026, 20:32 UTC

Ganhos

Aquisições, Fusões, Aquisições de Empresas

Synopsys Shares Fall Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

27 de mai. de 2026, 20:32 UTC

Aquisições, Fusões, Aquisições de Empresas

HCA Healthcare to Acquire The College of Health Care Professions for Undisclosed Terms >HCA

27 de mai. de 2026, 20:32 UTC

Aquisições, Fusões, Aquisições de Empresas

HCA Healthcare: Eric Bing Will Continue to Lead CHCP as Chancellor and CEO >HCA

27 de mai. de 2026, 20:30 UTC

Ganhos

Snowflake Beats Expectations and Expands AWS Ties Amid Software Sector Turmoil -- Barrons.com

27 de mai. de 2026, 20:30 UTC

Aquisições, Fusões, Aquisições de Empresas

HCA Healthcare Announces Agreement To Acquire The College Of Health Care Professions >HCA

27 de mai. de 2026, 20:22 UTC

Ganhos

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 de mai. de 2026, 20:16 UTC

Ganhos

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 de mai. de 2026, 20:13 UTC

Ganhos

Synopsys Sees 3Q Adj EPS $3.63-Adj EPS $3.69 >SNPS

27 de mai. de 2026, 20:13 UTC

Ganhos

Marvell Revenue Beats Estimates. The Stock Rises. -- Barrons.com

27 de mai. de 2026, 20:13 UTC

Ganhos

Synopsys Sees FY Adj EPS $14.72-Adj EPS $14.80 >SNPS

27 de mai. de 2026, 20:12 UTC

Ganhos

Synopsys Sees FY EPS $2.49-EPS $2.91 >SNPS

27 de mai. de 2026, 20:12 UTC

Ganhos

Synopsys Sees 3Q EPS 84c-EPS 98c >SNPS

Comparação entre Pares

Variação de preço

MannKind Corp Previsão

Preço-alvo

By TipRanks

116.15% parte superior

Previsão para 12 meses

Média 7.63 USD 116.15%

Máximo 10 USD

Mínimo 4.75 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para MannKind Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

Comprar

Manter

Vender

Com base em 6 analistas que deram avaliações de ações para MannKind Corp - Dist nos últimos 3 meses.

Sentimento

By Acuity

79 / 344 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.